sameAs
The clinical use of structural MRI in Alzheimer diseaseAltered temporal correlations in parietal alpha and prefrontal theta oscillations in early-stage Alzheimer diseaseA/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersPharmacological treatment of dementia: a scoping review of systematic reviewsDrug development in Alzheimer's disease: the path to 2025Slowing of Hippocampal Activity Correlates with Cognitive Decline in Early Onset Alzheimer's Disease. An MEG Study with Virtual Electrodes.Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stageEffect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx studyThe effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled studyCortico-hippocampal communication by way of parallel parahippocampal-subicular pathwaysClinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive declineAlzheimer's disease.Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients.Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theory.Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity.Alzheimer's disease: connecting findings from graph theoretical studies of brain networks.Declining functional connectivity and changing hub locations in Alzheimer's disease: an EEG studyAutomatic temporal lobe atrophy assessment in prodromal AD: Data from the DESCRIPA study.Imaging of white matter lesions.Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion.The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial.Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging.White matter hyperintensities, cognitive impairment and dementia: an update.Functional connectivity in elderly controls and AD patients using resting state fMRI: a pilot study.Pathological aging of the brain: an overview.Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study.Alzheimer Disease and Behavioral Variant Frontotemporal Dementia: Automatic Classification Based on Cortical Atrophy for Single-Subject Diagnosis.Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data.Brain imaging in patients with diabetes: a systematic review.Activity dependent degeneration explains hub vulnerability in Alzheimer's disease.Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRI.Effects of transcutaneous electrical nerve stimulation (TENS) on non-pain related cognitive and behavioural functioning.Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.Multi-center comparison of medial temporal atrophy in patients with Alzheimer's disease--data from the ICTUS study.Clinico-Pathological Correlations of the Frontal Lobe Syndrome: Results of a Large Brain Bank Study.Imaging in Alzheimer's disease.Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT.Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire.
P50
Q24609648-2D8E31D2-F187-46DE-B9B0-E6FA9577D9E5Q24658194-E1FDB5F2-A5D5-45D6-83E0-1CED00FFAB59Q26745508-8F0EC5C7-F149-4C86-99E8-569434809A92Q26823855-56A6B3F8-2198-4E15-B3C5-6579F0456CD6Q27007748-1C74C95E-89BB-412D-B629-EE3D3E1F1A77Q27315186-7CF02794-EAC5-4796-BB36-DB13B4A034F8Q27500371-D560F28C-A738-419A-9645-AB527BE8ADAAQ28302829-8DE78CE3-ACFB-49DA-A1A9-33FABF11A9B6Q28539196-93CB6426-DE95-42E3-8D90-C9644140B97DQ29302882-4E707B3B-012E-42B2-ACAA-98DB64F97171Q30235201-DD280D3A-7E24-442A-9AF5-8129EEB7C1E1Q30239789-2D791BAC-A309-4860-BB7C-6B8A887B6F6EQ30251865-C1806DD0-3A3B-4E88-A34A-F06843F43DEDQ30313120-033277AF-F8F7-4E99-9A73-058146D983C8Q30458193-399C8239-C7A8-4278-80B8-250F78FFD325Q30489923-6AE3736E-B837-421C-A87D-D0E4C2B0D29BQ30581493-66537AD0-E48C-4DFB-AB22-C7CB7A20E7F7Q30609249-F1005CEB-BEA6-4BB2-A1EA-E65FCAAB7FE1Q30662029-41E7E3F4-CD30-4684-AFFE-337EC5567F61Q30666806-91A84FCC-F387-40C0-B65F-1698BA8E220EQ30680385-FC5A5AC7-67AE-42EF-82EA-55F4A562CF82Q30810310-CDF279B6-E436-41AB-8726-C9DF877297D1Q30874688-14F2B6D5-E2F4-410E-BD67-F3F54784E1F1Q30887563-C5930B1E-E1B5-4B56-923B-8E986BAEF2A5Q30893715-F7ADA83B-42E0-4921-A97E-50EB97F096F2Q30992759-52E0368F-C179-4D0A-A852-8B6EE7FC8DB3Q30996023-BE7B53E9-17A7-4D8E-ABEA-4C94028EFA38Q31030767-35F3F92A-A29B-404F-A1B4-6ACAF6DD8C5DQ31031424-97F52E59-B9B0-4F8E-B4A6-6EC4AA0D3F5EQ31058235-449A8F80-68E4-4621-A27D-B994B53F9132Q31070335-02B18374-385B-4268-8795-A157075FFC00Q31086948-50DB35D2-DB57-4EE9-A0F0-8ED0E4734B14Q31108296-914C6B74-5F2B-4F89-9A20-D4E5E48F8DFCQ31116168-B950368A-8120-4325-97CE-DDDF626605BBQ33239536-3B90820A-6DC9-4AD6-ADFE-B9E48C906DAFQ33374508-74BCC4E5-8AF4-401E-B36F-05EF89BD8908Q33457451-88D0932D-57E9-4625-B0D7-6D7006FA6CCFQ33479675-892C8C7B-38DD-42B1-B5A8-BF7604675E32Q33487590-3DE4E001-C919-42CC-856C-2BF61A431D73Q33599659-7D2BF58B-CB0D-40BE-91F8-2960B7A05BC4
P50
description
Alzheimer researcher
@en
neuroloog
@nl
name
Philip Scheltens
@ast
Philip Scheltens
@en
Philip Scheltens
@es
Philip Scheltens
@nl
Philip Scheltens
@sl
type
label
Philip Scheltens
@ast
Philip Scheltens
@en
Philip Scheltens
@es
Philip Scheltens
@nl
Philip Scheltens
@sl
altLabel
P. Scheltens
@nl
prefLabel
Philip Scheltens
@ast
Philip Scheltens
@en
Philip Scheltens
@es
Philip Scheltens
@nl
Philip Scheltens
@sl
P1006
P1741
P214
P244
P1006
P1741
P21
P213
0000 0001 1055 2544
P214
P2381
P244
P2798
P31
P496
0000-0002-1046-6408
P5463
Scheltens_Philip
P569
1957-01-01T00:00:00Z
P691
P735
P7449
PRS1240990